Related Experiment Video
Updated: May 12, 2026

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
Published on: May 24, 2012
New developments in lentiviral vector design, production and purification.
Maria Mercedes Segura1, Mathias Mangion, Bruno Gaillet
1Chemical Engineering Department, Universitat Autònoma de Barcelona, Campus Bellaterra, Cerdanyola del Vallès (08193), Barcelona, Spain.
Recent advances in lentivirus vector production are resolving key challenges in gene therapy. Improved methods for constructing, producing, and purifying lentiviruses are making this potent gene therapy tool safer and more effective.
Area of Science:
- Biotechnology
- Gene Therapy
- Viral Vectors
Background:
- Lentiviruses are potent viral vectors with growing interest in gene therapy applications.
- State-of-the-art techniques are crucial for producing high-purity lentivirus vectors for safe and effective use.
Purpose of the Study:
- To review recent advances in recombinant lentivirus vector design, production, and purification.
- To provide guidance for users of lentivirus vector technology in gene therapy.
Main Methods:
- Review of recent literature on lentivirus vector development.
- Focus on state-of-the-art techniques for construction, production, and purification.
Main Results:
- Key challenges in lentivirus vector production, including low titer and purification difficulties, are being addressed.
- Recent advancements indicate these issues are nearing resolution.
Conclusions:
- Recombinant lentivirus vectors are becoming a mature technology for gene therapy.
- Improved production and purification methods enhance the utility and safety of lentivirus-based gene therapies.
More Related Videos
11:08Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
Published on: April 8, 2012
06:33Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice
Published on: February 16, 2024